BIOMAT Database Logo BIOMAT Database Logo

Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. EORTC Lung Cancer Cooperative Group. 1996

P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Department of Pulmonary Diseases, Free University Hospital, Amsterdam, The Netherlands.

Toxicity and response rates are evaluated in a randomized phase II study comparing paclitaxel (Taxol; Bristol-Myers Squibb Company, Princeton, NJ)/cisplatin with teniposide/cisplatin in the treatment of non-small cell lung cancer to decide whether this study should continue as a phase III trial. A response was seen in 26% (10 of 38) of the patients receiving teniposide/cisplatin and in 40% (14 of 35) of those receiving paclitaxel/cisplatin. Overall, evidence of toxicity was more severe in the cisplatin/teniposide group, especially with regard to myelotoxicity. Grade 4 neutropenia was seen in 66% of patients receiving teniposide compared with 29% of those treated with paclitaxel/cisplatin. The study is to continue as a phase III trial, with 150 patients expected to participate in each treatment group.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
December 1996, Seminars in oncology,
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group.
January 1993, European journal of cancer (Oxford, England : 1990),
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Preliminary results of a phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer.
August 1997, Seminars in oncology,
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Paclitaxel and cisplatin in patients with non-small cell lung cancer: results of a phase II trial.
October 1996, Seminars in oncology,
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Epirubicin in previously untreated patients with small cell lung cancer: a phase II study by the EORTC Lung Cancer Cooperative Group.
January 1992, European journal of cancer (Oxford, England : 1990),
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial.
October 2002, Annals of oncology : official journal of the European Society for Medical Oncology,
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Phase II study of ACNU as second-line treatment in small-cell lung cancer. EORTC Lung Cancer Cooperative Group.
January 1992, Cancer chemotherapy and pharmacology,
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.
June 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
[Early phase II study of BMS-181339 (paclitaxel) in patients with non-small cell lung cancer. BMS-181339 Non-Small Cell Lung Cancer Study Group].
May 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
P E Postmus, and G Giaccone, and C Debruyne, and T Sahmoud, and T A Splinter, and N van Zandwijk
Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer.
March 2004, British journal of cancer,
Copied contents to your clipboard!